Sachem Capital Corp. 7.125% Not
AMEX:SCCFREIT - Industrial
+$0.00 today
- Market cap
- $1.16B
- Beta
- 0.40
- P/E (TTM)
- 478.4
- EPS (TTM)
- $0.05
- Dividend yield
- 7.29%
Volume 0.00M
Average 0.00M
SCCF Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Sachem Capital Corp. 7.125% NotAMEX: SCCF
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How SCCF compares with its peers on the latest reported figures
- SCCF's LTM Mar 2026 research & development of $0 is the 3rd highest of the 8 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for SCCF, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $24.41M | +258.0% | +13.6% | 2491.1% | |
| LTM Mar 2026 | $22.29K | +2824.7% | — | 0.2% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SCCF) | $0 | +1541.3% | +13.6% | 0.0% | |
Competitors are the stored peer set for SCCF. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 20M | 30.62M | 29.97M | 57.5M | 46.94M |
| Cost of Revenue | 0 | 0 | 0 | 0 | 28.67M |
| Gross Profit | 20M | 30.62M | 29.97M | 57.5M | 18.27M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 38.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 5.37M | 8.41M | 11.89M | 13.67M | 14.14M |
| Operating Expenses | 5.37M | 8.41M | 14.93M | 75.28M | 13.1M |
| Depreciation & Amortization | 83.53K | 106.41K | 266K | 372K | 2.73M |
| EBITDA | 83.53K | 106.41K | 266K | (11.35M) | 9.04M |
| EBITDA Margin | 0.4% | 0.3% | 0.9% | -19.7% | 19.2% |
| Operating Income | 14.64M | 22.21M | 15.04M | (17.78M) | 5.17M |
| Operating Margin | 73.2% | 72.5% | 50.2% | -30.9% | 11.0% |
| Interest Income | 0 | 0 | 0 | 0 | 11.67M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (1.32M) | (1.3M) | 860K | (26.1M) | 1.14M |
| Income Before Tax | 13.32M | 20.91M | 15.9M | (43.88M) | 6.31M |
| Pre-Tax Margin | 66.6% | 68.3% | 53.0% | -76.3% | 13.4% |
| Income Tax Expense | 0 | 0 | 0 | (4.3M) | 0 |
| Net Income | 13.32M | 20.91M | 15.9M | (39.57M) | 6.31M |
| Net Margin | 66.6% | 68.3% | 53.0% | -68.8% | 13.4% |
| EPS (Basic) | 0.44 | 0.46 | 0.27 | (0.93) | 0.04 |
| EPS (Diluted) | 0.44 | 0.46 | 0.27 | (0.93) | 0.04 |
| Weighted Avg Shares | 26.32M | 37.74M | 44.24M | 47.41M | 46.89M |
| Weighted Avg Shares (Diluted) | 26.32M | 37.75M | 44.24M | 47.41M | 46.89M |
Sachem Capital Corp. 7.125% Not
AMEX:SCCF
Intrinsic Alpha fair value
Locked
Current Price
$24.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.